Tackling NCD in LMIC: Achievements and Lessons Learned From the NHLBI-UnitedHealth Global Health Centers of Excellence Program.

Tackling NCD in LMIC: Achievements and Lessons Learned From the NHLBI-UnitedHealth Global Health Centers of Excellence Program.
复制标题

DOI:
10.1016/j.gheart.2015.12.016
复制
发表时间:
2016-03
期刊:
影响因子:
3.7
通讯作者:
National Health, Lung, and Blood Institute–UnitedHealth Global Health Centers of Excellence Collaborators
National Health, Lung, and Blood Institute–UnitedHealth Global Health Centers of Excellence Collaborators
中科院分区:
医学4区
文献类型:
--
作者:
Engelgau MM;Sampson UK;Rabadan-Diehl C;Smith R;Miranda J;Bloomfield GS;Belis D;Narayan KM;National Health, Lung, and Blood Institute–UnitedHealth Global Health Centers of Excellence Collaborators

文献摘要

被引文献

相似文献

从1990年到2010年,全球非传染性疾病负担从占总疾病负担的43%增加到54%。1 2012年,全球近四分之三(74%)的非传染性疾病负担发生在低收入和中等收入国家。2人口增长和人口老龄化对非传染性疾病负担趋势的扩大起到了很大的作用,这两种情况都在低收入和中等收入国家人口中迅速发生。3,4在低收入和中等收入国家环境中有效应对这种日益严重的非传染性疾病负担是一项重大挑战,但也是一项可以实现的任务。2,3,5今天,有许多有效的非传染性疾病干预措施。世界经济论坛和世界卫生组织(世卫组织)最近编写了一份针对决策者、民间社会和私营部门的报告,评估了非传染性疾病的经济影响以及在中低收入国家扩大经证明有效的核心干预措施的成本。6然而,在中低收入国家应对这些挑战需要当地的研究能力建设,7以便通过在中低收入国家进行的研究提供的国内知识基础来推动干预措施。然而,低收入和中等收入国家的研究基础设施和产出严重不足,来自这些环境的数据也很稀缺。3,8这种情况对实施已知的干预措施以及应对低收入和中等收入国家的疾病模式造成了问题,这些疾病的表型可能与高收入国家不同。
Between 1990 and 2010 the global non-communicable diseases (NCDs) burden increased from 43% to 54% of the total disease burden. 1 In 2012, globally, almost three quarters (74%) of all the NCD burden occurred in low-and middle-income countries. 2 Population growth and population aging have contributed substantially to the expanding NCD burden trends–both of which are rapidly occurring within low and middle income country populations. 3, 4 Effectively tackling this growing NCD burden in low-and middle-income country settings presents a major challenge, yet, is an achievable task. 2, 3, 5Today, many effective NCD interventions are available. The World Economic Forum and World Health Organization (WHO) recently developed a report targeted at decision makers, civil society, and the private sector, that provides assessments of the economic impact of noncommunicable diseases and costs of scaling up a core of proven-effective interventions within low-and middle income counties. 6 However, responding to these challenges in lowand middle-income countries will need local research capacity building, 7 so that interventions are driven by in-country knowledge-bases provided through research performed in low-and middle-income countries. Yet, research infrastructure and outputs in low and middle income countries are woefully inadequate, and the data from these settings are scarce. 3, 8 This situation poses problems both for implementation of known interventions and also for tackling low-and middle-income country disease patterns, phenotypes that might differ from high-income countries.